Parabilis Medicines Shares Rocket Following Record Biotech IPO - Stock Watch Index

Parabilis Medicines Shares Rocket Following Record Biotech IPO

June 10, 2026

Oncology-focused drug company nabs $670 million in scorching stock-market debut.

Search

RECENT PRESS RELEASES

Bolivia moves to formalize mining permits without environmental licenses, and the plan reopens the clash between enforcement, revenue, and the ecological cost of “legalizing” the irregular

SWI Editorial Staff2026-06-11T10:30:00-07:00June 11, 2026|

From startup to $1.8 trillion: The investors who took a chance on SpaceX now reap the rewa

SWI Editorial Staff2026-06-11T10:28:37-07:00June 11, 2026|

Lovelace Health System cuts 43 employees amid ‘challenging policy environment’

SWI Editorial Staff2026-06-11T10:24:54-07:00June 11, 2026|

Star51 Capital announces first medtech venture fund close

SWI Editorial Staff2026-06-11T10:23:21-07:00June 11, 2026|

Forbes AI Leader Hema Dey Debuts as Amazon Bestseller With The AI Translator Launching a Global Movement to

SWI Editorial Staff2026-06-11T10:17:10-07:00June 11, 2026|

Canadian mother sues OpenAI, alleging ChatGPT led her daughter to kill herself

SWI Editorial Staff2026-06-11T10:17:07-07:00June 11, 2026|

Related Post